SavedAdd your journal

Journals / Experimental and Applied Medical Science / 2026 / Cilt: 6 Sayı: 3

The Impact of Symptoms on Quality of Life in Individuals with Benign Prostatic Hyperplasia

Benign Prostat Hiperplazisi olan bireylerde semptomların yaşam kalitesi üzerine etkileri

Demet Çelik(KARAMANOĞLU MEHMETBEY ÜNİVERSİTESİ)0000-0002-4838-0714
Ahmet Şanlı(KARAMANOGLU MEHMETBEY UNIVERSITY)0000-0001-8237-1072
Pages
259–268
Publication Date
2025-10-10
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The mean age of the participants was 62.89±9.44 years, and it was found that 45.7% of them had been experiencing lower urinary tract symptoms for two years or more.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study is aimed to evaluate the relationship between symptoms and quality of life in patients diagnosed with Benign Prostatic Hyperplasia (BPH).
📊
Key Findings & Data:Methods: The study was descriptive and cross-sectional. 232 patients who have BPH in the study.
💡
Conclusion & Impact:Results: The mean age of the participants was 62.89±9.44 years, and it was found that 45.7% of them had been experiencing lower urinary tract symptoms for two years or more.
🔬Design:Survey & Empirical Study
📍Scope:2024 Verileri
⚙️Variables:Beningn prostat hiperplazisi · Prostat Semptomları · Yaşam kalitesi

Abstract

Objective: This study is aimed to evaluate the relationship between symptoms and quality of life in patients diagnosed with Benign Prostatic Hyperplasia (BPH). Methods: The study was descriptive and cross-sectional. 232 patients who have BPH in the study. The data was collected from patients previously diagnosed with BPH between June 2024 and October 2025 using The Demographic Characteristics Questionnaire, The International Prostate Symptom Score (IPSS), and The Quality of Life in Benign Prostatic Hyperplasia (QUALIPROST) tools. Results: The mean age of the participants was 62.89±9.44 years, and it was found that 45.7% of them had been experiencing lower urinary tract symptoms for two years or more. The mean total IPSS score of the patients was 13.77±6.44, while the mean total QUALIPROST score was determined to be 22.57±10.59. A moderate negative correlation was identified between the IPSS and the quality of life score in BPH patients. Conclusion: BPH has been effective fo the quality of life. Identifying patient-specific quality of life is crucial in treatment selection and follow-up.

Özet

Amaç: Bu çalışmada, Benign Prostat Hiperplazisi (BPH) tanısı almış hastalarda semptomlar ve yaşam kalitesi arasındaki ilişkinin değerlendirilmesi amaçlanmıştır. Yöntemler: Çalışma tanımlayıcı ve kesitseldir. Çalışmaya BPH'si olan 232 hasta dahil edilmiştir. Veriler, Haziran 2024 ile Ekim 2025 arasında daha önce BPH tanısı almış hastalardan Demografik Özellikler Anketi, Uluslararası Prostat Semptom Skoru (UPSS) ve Benign Prostat Hiperplazisinde Yaşam Kalitesi (BPHYK) araçları kullanılarak toplanmıştır. Sonuçlar: Katılımcıların yaş ortalaması 62.89±9,44 yıl olup, %45.7'sinin alt üriner sistem semptomlarını iki yıl veya daha uzun süredir yaşadığı bulunmuştur. Hastaların ortalama toplam UPSS skoru 13.77±6.44 iken, ortalama toplam BPHYK skoru 22.57±10.59 olarak belirlenmiştir. BPH hastalarında UPSS ile yaşam kalitesi skoru arasında orta düzeyde negatif bir korelasyon tespit edildi. Sonuç: BPH yaşam kalitesi üzerinde etkili olmuştur. Hastaya özgü yaşam kalitesinin belirlenmesi tedavi seçimi ve takibinde çok önemlidir

🔖

Cite This Article

Çelik, D., Şanlı, A. (2025). The Impact of Symptoms on Quality of Life in Individuals with Benign Prostatic Hyperplasia. Experimental and Applied Medical Science, Cilt: 6 Sayı: 3, 259–268. https://doi.org/10.46871/eams.1678248

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (31)

  1. References 1. Bulut CE, Atan A. Pathophysiology of BPH. Andrology Bulletin. 2023; 25(3): 181-189. doi:10.24898/tandro.2023.91328
  2. Özen M. Male Lower Urinary Tract symptoms/Benign prostatic hyperplasia. J Fam Med-Special Topics. 2016; 7(4): 26-33.
  3. Çam K. Why is quality of life important in benign prostatic hyperplasia and how is it measured? Bulletin of Urooncology. 2009; 8(4): 21-24.
  4. Danacı M. Benign prostatic hyperplasia. Turk Radiol Semin. 2017; 5(3): 482-490.
  5. İbiş AM, Özkaya FM, Yaman Ö. Preservation techniques of ejaculation in the surgical treatment of lower urinary tract symptoms/benign prostatic hyperplasia. Turkiye Klinikleri Journal of Urology Special Topics. 2024; 82-86.
  6. Ng M, Leslie SW, Baradhi KM. Benign prostatic hyperplasia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
  7. Wang CK, Zhang JH, Gao Y, Meng XY, Zhang HX, Luo HH. Quality of life and influencing factors in older adults with benign prostatic hyperplasia. International Journal of Urological Nursing. 2024; 18(1): e12391.
  8. Inouye BM, Hughes FM Jr, Jin H, Lütolf R, Potnis KC, Routh JC, et al. Diabetic bladder dysfunction is associated with bladder inflammation triggered through hyperglycemia, not polyuria. Research and Reports in Urology. 2018; 16(10): 219-225.
  9. Yurtseven Ş, Aslan S. Quality of life and sleep in patients who have transurethral prostate resection. Uluborlu Journal of Vocational Sciences. 2023; 6(1): 124-128.
  10. Park S, Ryu JM, Lee M. Quality of life in older adults with Benign Prostatic Hyperplasia. Healthcare. 2020; 8(2): 158.
  11. Skopljak A, Prasko S, Prasko E, Mujčić AK, Čampara MT, Hukić F, et al. Assessment of symptoms and signs of benign prostatic hyperplasia using the International Prostate Symptom Score in clinical practice. World Journal of Advanced Research and Reviews. 2024; 21(3): 2421-2428.
  12. Esin NM. Sampling. In: Erdoğan S, Nahcivan N, Esin MN, editors. Research in nursing: process, practice and critique, 2nd Edition. Nobel Medical Bookstores; 2024. p. 167-192.
  13. Mebust WK, Bosch R, Dovovan J. Symptom evaluation, quality of life and sexuality. In Cockett ATK, Khoury S, Aso Y, eds. Proceedings of the Second International Consultation of Benign Prostate Hyperplasia. 1993: 131-138.
  14. Cam K. Why is quality of life important in benign prostatic hyperplasia and how is it measured? Urooncology Bulletin. 2009; 4: 21-24.
  15. Karabıçak M, Türk H, Ün S, Arslan E, Oğütlü A. Retrospective evaluation of alpha blocker therapy in obese patients with benign prostatic hyperplasia. Aegean Journal of Medical Science. 2019; 2(3): 129-133.
  16. Hamza BK, Ahmed M, Bello A, Tolani MA, Awaisu M, Lawal AT, Oyelowo, Abdulsalam KL, Lawal L, Sudi A, Maitama HY. Correlation of intravesical prostatic protrusion with severity of lower urinary symptoms among patients with benign prostatic hyperplasia. African Journal of Urology. 2021; 27(4).
  17. Güzelsoy M, Erkan A, Öztürk M, Zengin S, Çoban S, Turkoglu AR, Koç A. Comparison of three questionnaire forms used in the diagnosis of lower urinary tract symptoms: A prospective study. Prostate International. 2022; 10(4): 218-223.
  18. Shin YS, Soni KK, Lee DY, Kam SC. The relationship between depression, anxiety and lower urinary tract symptoms in men. Prostate International. 2024; 12(2): 86-89.
  19. Demirbağ A, Ermeç B, Bayrak Ö, Kadıoğlu A. Medical treatment choice for male lower urinary tract symptoms. Continence and Neurourology Bulletin. 2015; 2:74-8.
  20. Tong Y, Xie K, Li S. Self-care and quality of life in elderly Chinese patients with benign prostatic hyperplasia. Nursing Science Quarterly. 2020; 33(1): 79-84.
  21. Kaya M, Özkan M. Determination of preoperative and postoperative quality of life of benign prostatic hyperplasia patients. Perspectives in Palliative & Home Care. 2023; 2(2): 63-74.
  22. Güler E, Ersoy S, Pala E. Symptoms of benign prostate hypertrophy and its effect on life quality in males over 50. Medical Records. 2021; 3(2): 138-145.
  23. Seok Y, Yi M. Quality of life and its related factors in patients with benign prostatic hyperplasia in one general hospital. Journal of Korean Clinical Nursing Research. 2017; 23(3): 332-340.
  24. Pinto JD, He HG, Chan SW, Wang W. Health-related quality of life and psychological well-being in men with benign prostatic hyperplasia: An integrative review. Jpn J Nurs Sci. 2016; 13(3): 309-323.
  25. Speakman M, Kirby R, Doyle S, Ioannou C. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH)-focus on the UK. BJU International. 2015; 115(4): 508-519. doi: 10.1111/bju.12745.
  26. Erkoc M, Otunctemur A, Besiroglu H, Altunrende F. Evaluation of quality of life in patients undergoing surgery for benign prostatic hyperplasia. Aging Male. 2018; 21(4): 238-242. doi: 10.1080/13685538.2018.1433654.
  27. Foo KT. What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?. World Journal of Urology. 2019; 37(7): 1293-1296. doi: 10.1007/s00345-019-02691-0.
  28. Karimi M, Brazier J. Health, health-related quality of life, and quality of life: What is the difference? Pharmacoeconomics. 2016; 34(7): 645-649. doi: 10.1007/s40273-016-0389-9.
  29. Braeckman J, Denis L. Management of BPH then 2000 and now 2016–from BPH to BPO. Asian Journal of Urology. 2017; 4(3): 138-147. doi: 10.1016/j.ajur.2017.02.002.
  30. Varughese S, Rajeev TP, Rodrigues DE. Effect of nocturia on quality of life among clients with benign prostatic hyperplasia. Indian Journal of Community Medicine. 2021; 46(2): 346-347. doi:10.4103/ijcm.IJCM_599_20.
  31. Egan KB. The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: Prevalence and incident rates. Urol Clin North Am. 2016; 43(3): 289-297. doi: 10.1016/j.ucl.2016.04.001.